Beck Mack & Oliver’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.4M | Sell |
|
|||||
|
2025
Q1 | $18M | Sell |
|
|||||
|
2024
Q4 | $26.4M | Sell |
|
|||||
|
2024
Q3 | $22.2M | Sell |
|
|||||
|
2024
Q2 | $21.2M | Sell |
|
|||||
|
2024
Q1 | $26.7M | Sell |
|
|||||
|
2023
Q4 | $25.4M | Sell |
|
|||||
|
2023
Q3 | $32.4M | Sell |
|
|||||
|
2023
Q2 | $28.1M | Sell |
|
|||||
|
2023
Q1 | $50.4M | Sell |
|
|||||
|
2022
Q4 | $58M | Sell |
|
|||||
|
2022
Q3 | $60.8M | Buy |
|
|||||
|
2022
Q2 | $48.6M | Buy |
|
|||||
|
2022
Q1 | $59.4M | Buy |
|
|||||
|
2021
Q4 | $44M | Sell |
|
|||||
|
2021
Q3 | $71.7M | Buy |
|
|||||
|
2021
Q2 | $44M | Buy |
|
|||||
|
2021
Q1 | $47.2M | Buy |
|
|||||
|
2020
Q4 | $37.7M | Sell |
|
|||||
|
2020
Q3 | $36.8M | Buy |
|
|||||
|
2020
Q2 | $49.3M | Buy |
|
|||||
|
2020
Q1 | $35.6M | Buy |
|
|||||
|
2019
Q4 | $29M | Buy |
|
|||||
|
2019
Q3 | $16.6M | Buy |
|
|||||
|
2019
Q2 | $16.3M | Sell |
|
|||||
|
2019
Q1 | $65.3M | Buy |
|
|||||
|
2018
Q4 | $53.8M | Buy |
|
|||||
|
2018
Q3 | $64.5M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $1.37M | Sell |
|
|||||
|
2015
Q2 | $1.53M | Hold |
|
|||||
|
2015
Q1 | $1.62M | Hold |
|
|||||
|
2014
Q4 | $1.49M | Buy |
|
|||||
|
2014
Q3 | $1.39M | Buy |
|
|||||
|
2014
Q2 | $1.35M | Sell |
|
|||||
|
2014
Q1 | $1.46M | Hold |
|
|||||
|
2013
Q4 | $1.1M | Sell |
|
|||||
|
2013
Q3 | $1.04M | Sell |
|
|||||
|
2013
Q2 | $1.22M | Buy |
|